ID   MCES_HUMAN              Reviewed;         476 AA.
AC   O43148; B0YJ90; D3DUJ5; O94996; Q9UIJ9;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=mRNA cap guanine-N7 methyltransferase;
DE            EC=2.1.1.56;
DE   AltName: Full=RG7MT1;
DE   AltName: Full=mRNA (guanine-N(7)-)-methyltransferase;
DE   AltName: Full=mRNA cap methyltransferase;
DE            Short=hCMT1;
DE            Short=hMet;
DE            Short=hcm1p;
GN   Name=RNMT; Synonyms=KIAA0398;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9790902; DOI=10.1006/bbrc.1998.9402;
RA   Tsukamoto T., Shibagaki Y., Niikura Y., Kiyohisa M.;
RT   "Cloning and characterization of three human cDNAs encoding mRNA
RT   (guanine-7-)methyltransferase, an mRNA cap methylase.";
RL   Biochem. Biophys. Res. Commun. 251:27-34(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH POLYMERASE II AND RNGTT.
RX   PubMed=9705270; DOI=10.1074/jbc.273.34.21443;
RA   Pillutla R.C., Yue Z., Maldonado E., Shatkin A.J.;
RT   "Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA
RT   polymerase IIo complexes.";
RL   J. Biol. Chem. 273:21443-21446(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10589710;
RA   Yamada-Okabe T., Mio T., Kashima Y., Matsui M., Arisawa M.,
RA   Yamada-Okabe H.;
RT   "The Candida albicans gene for mRNA 5'-cap methyltransferase:
RT   identification of the additional residues essential for catalysis.";
RL   Microbiology 145:3023-3033(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF ASP-203; ARG-239; TYR-289; PHE-291 AND
RP   PHE-354.
RX   PubMed=10347220; DOI=10.1074/jbc.274.23.16553;
RA   Saha N., Schwer B., Shuman S.;
RT   "Characterization of human, Schizosaccharomyces pombe, and Candida
RT   albicans mRNA cap methyltransferases and complete replacement of the
RT   yeast capping apparatus by mammalian enzymes.";
RL   J. Biol. Chem. 274:16553-16562(1999).
RN   [9]
RP   SUBCELLULAR LOCATION, RNA-BINDING, AND INTERACTION WITH IMPORTIN
RP   ALPHA.
RX   PubMed=11114884; DOI=10.1101/gad.848200;
RA   Wen Y., Shatkin A.J.;
RT   "Cap methyltransferase selective binding and methylation of GpppG-RNA
RT   are stimulated by importin-alpha.";
RL   Genes Dev. 14:2944-2949(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 80-LYS--LYS-83;
RP   103-LYS--ARG-107 AND ARG-127.
RX   PubMed=15767670; DOI=10.1128/MCB.25.7.2644-2649.2005;
RA   Shafer B., Chu C., Shatkin A.J.;
RT   "Human mRNA cap methyltransferase: alternative nuclear localization
RT   signal motifs ensure nuclear localization required for viability.";
RL   Mol. Cell. Biol. 25:2644-2649(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH RAM/FAM103A1.
RX   PubMed=22099306; DOI=10.1016/j.molcel.2011.08.041;
RA   Gonatopoulos-Pournatzis T., Dunn S., Bounds R., Cowling V.H.;
RT   "RAM/Fam103a1 is required for mRNA cap methylation.";
RL   Mol. Cell 44:585-596(2011).
CC   -!- FUNCTION: mRNA-capping methyltransferase that methylates the N7
CC       position of the added guanosine to the 5'-cap structure of mRNAs.
CC       Binds RNA containing 5'-terminal GpppC.
CC       {ECO:0000269|PubMed:10347220, ECO:0000269|PubMed:22099306,
CC       ECO:0000269|PubMed:9705270, ECO:0000269|PubMed:9790902}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + G(5')pppR-RNA = S-
CC       adenosyl-L-homocysteine + m(7)G(5')pppR-RNA. {ECO:0000255|PROSITE-
CC       ProRule:PRU00895}.
CC   -!- SUBUNIT: Interacts with importin alpha, leading to stimulate both
CC       RNA-binding and methyltransferase activity. Interaction with
CC       importin alpha and beta is required for its nuclear localization,
CC       importin beta dissociating in response to RanGTP, allowing RNMT-
CC       importin alpha to bind RNA substrates. Interacts with elongating
CC       form of polymerase II and RNGTT. Interacts with RAM/FAM103A1, the
CC       interaction significantly enhances RNA-binding and cap
CC       methyltransferase activity. {ECO:0000269|PubMed:11114884,
CC       ECO:0000269|PubMed:22099306, ECO:0000269|PubMed:9705270}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11114884,
CC       ECO:0000269|PubMed:15767670}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=hCMT1a;
CC         IsoId=O43148-1; Sequence=Displayed;
CC       Name=2; Synonyms=hCMT1b;
CC         IsoId=O43148-2; Sequence=VSP_020241;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9705270,
CC       ECO:0000269|PubMed:9790902}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. mRNA cap 0 methyltransferase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00895}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022604; BAA74464.1; -; mRNA.
DR   EMBL; AB022605; BAA74463.1; -; mRNA.
DR   EMBL; AF067791; AAC63269.1; -; mRNA.
DR   EMBL; AB020966; BAA82447.1; -; mRNA.
DR   EMBL; AB007858; BAA23694.1; -; mRNA.
DR   EMBL; EF445026; ACA06068.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01505.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01506.1; -; Genomic_DNA.
DR   EMBL; BC036798; AAH36798.1; -; mRNA.
DR   CCDS; CCDS11867.1; -. [O43148-1]
DR   CCDS; CCDS77156.1; -. [O43148-2]
DR   RefSeq; NP_001295192.1; NM_001308263.1. [O43148-2]
DR   RefSeq; NP_003790.1; NM_003799.2. [O43148-1]
DR   RefSeq; XP_005258219.1; XM_005258162.1. [O43148-1]
DR   RefSeq; XP_016881550.1; XM_017026061.1. [O43148-2]
DR   UniGene; Hs.592347; -.
DR   PDB; 3BGV; X-ray; 2.30 A; A/B/C/D=165-476.
DR   PDB; 3EPP; X-ray; 2.41 A; A/B=165-476.
DR   PDB; 5E8J; X-ray; 2.35 A; A/B=165-476.
DR   PDB; 5E9J; X-ray; 3.47 A; A/B=167-416, A/B=457-476.
DR   PDB; 5E9W; X-ray; 2.28 A; A/B/C/D=165-476.
DR   PDBsum; 3BGV; -.
DR   PDBsum; 3EPP; -.
DR   PDBsum; 5E8J; -.
DR   PDBsum; 5E9J; -.
DR   PDBsum; 5E9W; -.
DR   ProteinModelPortal; O43148; -.
DR   SMR; O43148; -.
DR   BioGrid; 114269; 19.
DR   IntAct; O43148; 7.
DR   STRING; 9606.ENSP00000262173; -.
DR   iPTMnet; O43148; -.
DR   PhosphoSitePlus; O43148; -.
DR   BioMuta; RNMT; -.
DR   EPD; O43148; -.
DR   MaxQB; O43148; -.
DR   PaxDb; O43148; -.
DR   PeptideAtlas; O43148; -.
DR   PRIDE; O43148; -.
DR   Ensembl; ENST00000262173; ENSP00000262173; ENSG00000101654. [O43148-1]
DR   Ensembl; ENST00000383314; ENSP00000372804; ENSG00000101654. [O43148-1]
DR   Ensembl; ENST00000543302; ENSP00000446426; ENSG00000101654. [O43148-1]
DR   Ensembl; ENST00000589866; ENSP00000466252; ENSG00000101654. [O43148-1]
DR   Ensembl; ENST00000592764; ENSP00000466111; ENSG00000101654. [O43148-2]
DR   GeneID; 8731; -.
DR   KEGG; hsa:8731; -.
DR   UCSC; uc002ksk.2; human. [O43148-1]
DR   CTD; 8731; -.
DR   DisGeNET; 8731; -.
DR   GeneCards; RNMT; -.
DR   HGNC; HGNC:10075; RNMT.
DR   HPA; HPA039409; -.
DR   MalaCards; RNMT; -.
DR   MIM; 603514; gene.
DR   neXtProt; NX_O43148; -.
DR   OpenTargets; ENSG00000101654; -.
DR   PharmGKB; PA34448; -.
DR   eggNOG; KOG1975; Eukaryota.
DR   eggNOG; ENOG410Y7HG; LUCA.
DR   GeneTree; ENSGT00390000002368; -.
DR   HOVERGEN; HBG081963; -.
DR   InParanoid; O43148; -.
DR   KO; K00565; -.
DR   OMA; PAMQFIL; -.
DR   OrthoDB; EOG091G0C9Y; -.
DR   PhylomeDB; O43148; -.
DR   TreeFam; TF314347; -.
DR   BioCyc; MetaCyc:HS02296-MONOMER; -.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   ChiTaRS; RNMT; human.
DR   EvolutionaryTrace; O43148; -.
DR   GeneWiki; MRNA_(guanine-N7-)-methyltransferase; -.
DR   GeneWiki; RNMT; -.
DR   GenomeRNAi; 8731; -.
DR   PRO; PR:O43148; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101654; -.
DR   CleanEx; HS_RNMT; -.
DR   ExpressionAtlas; O43148; baseline and differential.
DR   Genevisible; O43148; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005845; C:mRNA cap binding complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IMP:UniProtKB.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; IMP:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR016899; mRNA_G-N7_MeTrfase.
DR   InterPro; IPR004971; mRNA_G-N7_MeTrfase_dom.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF03291; Pox_MCEL; 1.
DR   PIRSF; PIRSF028762; ABD1; 1.
DR   SUPFAM; SSF53335; SSF53335; 2.
DR   PROSITE; PS51562; RNA_CAP0_MT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Methyltransferase; mRNA capping; mRNA processing; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding;
KW   S-adenosyl-L-methionine; Transferase.
FT   CHAIN         1    476       mRNA cap guanine-N7 methyltransferase.
FT                                /FTId=PRO_0000248321.
FT   DOMAIN      128    476       mRNA cap 0 methyltransferase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00895}.
FT   REGION      176    177       mRNA cap binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   REGION      261    262       S-adenosyl-L-methionine binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00895}.
FT   REGION      284    286       S-adenosyl-L-methionine binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00895}.
FT   MOTIF       126    128       Nuclear localization signal.
FT   BINDING     180    180       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00895}.
FT   BINDING     205    205       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   BINDING     227    227       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00895}.
FT   BINDING     288    288       mRNA cap. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   BINDING     370    370       mRNA cap. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   BINDING     467    467       mRNA cap. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   SITE        208    208       mRNA cap binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   SITE        214    214       mRNA cap binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   SITE        239    239       mRNA cap binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00895}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D0L8}.
FT   MOD_RES      28     28       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D0L8}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5U2U7}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5U2U7}.
FT   VAR_SEQ     465    476       SIYLVFAFEKQQ -> RLTVTIMREAWLSTVGPGRAPVAAS
FT                                SVKWGTPRPAMQFIL (in isoform 2).
FT                                {ECO:0000303|PubMed:9790902}.
FT                                /FTId=VSP_020241.
FT   MUTAGEN      80     83       KKRK->AAAA: Does not abolish nuclear
FT                                localization. Abolishes nuclear
FT                                localization; when associated with 103-
FT                                AAAAA-107 and I-127.
FT                                {ECO:0000269|PubMed:15767670}.
FT   MUTAGEN     103    107       KKRKR->AAAAA: Does not abolish nuclear
FT                                localization. Abolishes nuclear
FT                                localization; when associated with 80-
FT                                AAAA-83 and I-127.
FT                                {ECO:0000269|PubMed:15767670}.
FT   MUTAGEN     127    127       R->I: Does not abolish nuclear
FT                                localization. Abolishes nuclear
FT                                localization; when associated with 80-
FT                                AAAA-83 and 103-AAAAA-107.
FT                                {ECO:0000269|PubMed:15767670}.
FT   MUTAGEN     203    203       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10347220}.
FT   MUTAGEN     239    239       R->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10347220}.
FT   MUTAGEN     289    289       Y->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10347220}.
FT   MUTAGEN     291    291       F->A: Strongly impairs enzyme activity.
FT                                {ECO:0000269|PubMed:10347220}.
FT   MUTAGEN     354    354       F->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10347220}.
FT   CONFLICT    179    179       M -> I (in Ref. 3; BAA82447).
FT                                {ECO:0000305}.
FT   HELIX       170    193       {ECO:0000244|PDB:5E9W}.
FT   STRAND      200    204       {ECO:0000244|PDB:5E9W}.
FT   TURN        207    211       {ECO:0000244|PDB:5E9W}.
FT   HELIX       212    217       {ECO:0000244|PDB:5E9W}.
FT   STRAND      221    228       {ECO:0000244|PDB:5E9W}.
FT   HELIX       230    244       {ECO:0000244|PDB:5E9W}.
FT   STRAND      245    248       {ECO:0000244|PDB:5E9W}.
FT   STRAND      254    259       {ECO:0000244|PDB:5E9W}.
FT   TURN        262    264       {ECO:0000244|PDB:5E9W}.
FT   HELIX       267    269       {ECO:0000244|PDB:5E9W}.
FT   STRAND      271    273       {ECO:0000244|PDB:5E8J}.
FT   STRAND      278    285       {ECO:0000244|PDB:5E9W}.
FT   HELIX       287    292       {ECO:0000244|PDB:5E9W}.
FT   HELIX       294    305       {ECO:0000244|PDB:5E9W}.
FT   STRAND      308    319       {ECO:0000244|PDB:5E9W}.
FT   HELIX       321    330       {ECO:0000244|PDB:5E9W}.
FT   STRAND      331    337       {ECO:0000244|PDB:5E9W}.
FT   STRAND      339    346       {ECO:0000244|PDB:5E9W}.
FT   STRAND      357    362       {ECO:0000244|PDB:5E9W}.
FT   TURN        363    365       {ECO:0000244|PDB:5E8J}.
FT   STRAND      368    371       {ECO:0000244|PDB:5E9W}.
FT   HELIX       375    382       {ECO:0000244|PDB:5E9W}.
FT   HELIX       383    385       {ECO:0000244|PDB:5E9W}.
FT   STRAND      387    394       {ECO:0000244|PDB:5E9W}.
FT   HELIX       395    402       {ECO:0000244|PDB:5E9W}.
FT   HELIX       406    414       {ECO:0000244|PDB:5E9W}.
FT   STRAND      418    422       {ECO:0000244|PDB:5E8J}.
FT   TURN        434    437       {ECO:0000244|PDB:5E8J}.
FT   HELIX       438    443       {ECO:0000244|PDB:5E8J}.
FT   STRAND      453    456       {ECO:0000244|PDB:5E9W}.
FT   HELIX       458    464       {ECO:0000244|PDB:5E9W}.
FT   STRAND      467    474       {ECO:0000244|PDB:5E9W}.
SQ   SEQUENCE   476 AA;  54844 MW;  EC919BC41BD5E2B3 CRC64;
     MANSAKAEEY EKMSLEQAKA SVNSETESSF NINENTTASG TGLSEKTSVC RQVDIARKRK
     EFEDDLVKES SSCGKDTPSK KRKLDPEIVP EEKDCGDAEG NSKKRKRETE DVPKDKSSTG
     DGTQNKRKIA LEDVPEKQKN LEEGHSSTVA AHYNELQEVG LEKRSQSRIF YLRNFNNWMK
     SVLIGEFLEK VRQKKKRDIT VLDLGCGKGG DLLKWKKGRI NKLVCTDIAD VSVKQCQQRY
     EDMKNRRDSE YIFSAEFITA DSSKELLIDK FRDPQMCFDI CSCQFVCHYS FESYEQADMM
     LRNACERLSP GGYFIGTTPN SFELIRRLEA SETESFGNEI YTVKFQKKGD YPLFGCKYDF
     NLEGVVDVPE FLVYFPLLNE MAKKYNMKLV YKKTFLEFYE EKIKNNENKM LLKRMQALEP
     YPANESSKLV SEKVDDYEHA AKYMKNSQVR LPLGTLSKSE WEATSIYLVF AFEKQQ
//
